Business Description
Cofco Biotechnology Co Ltd
ISIN : CNE000000ZR7
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.39 | |||||
Debt-to-EBITDA | -60.49 | |||||
Interest Coverage | 3.51 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.46 | |||||
Beneish M-Score | -2.82 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1 | |||||
3-Year EBITDA Growth Rate | -63.8 | |||||
3-Year Book Growth Rate | 0.2 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.83 | |||||
9-Day RSI | 50.65 | |||||
14-Day RSI | 52.72 | |||||
3-1 Month Momentum % | 32.16 | |||||
6-1 Month Momentum % | 6.95 | |||||
12-1 Month Momentum % | -11.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.2 | |||||
Quick Ratio | 0.81 | |||||
Cash Ratio | 0.29 | |||||
Days Inventory | 55.04 | |||||
Days Sales Outstanding | 20.53 | |||||
Days Payable | 15.23 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 229 | |||||
Shareholder Yield % | 4.25 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 6.76 | |||||
Operating Margin % | 1.78 | |||||
Net Margin % | -1.25 | |||||
FCF Margin % | 1.61 | |||||
ROE % | -2.47 | |||||
ROA % | -1.48 | |||||
ROIC % | 3.59 | |||||
3-Year ROIIC % | 22.41 | |||||
ROC (Joel Greenblatt) % | -0.56 | |||||
ROCE % | -0.58 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 55.98 | |||||
Shiller PE Ratio | 43.85 | |||||
PS Ratio | 0.53 | |||||
PB Ratio | 1.06 | |||||
Price-to-Tangible-Book | 1.17 | |||||
Price-to-Free-Cash-Flow | 32.2 | |||||
Price-to-Operating-Cash-Flow | 13.87 | |||||
EV-to-EBIT | -201.98 | |||||
EV-to-EBITDA | -201.98 | |||||
EV-to-Revenue | 0.65 | |||||
EV-to-FCF | 40.36 | |||||
Price-to-GF-Value | 0.75 | |||||
Price-to-Projected-FCF | 0.86 | |||||
Price-to-Median-PS-Value | 0.65 | |||||
Price-to-Graham-Number | 1.68 | |||||
Price-to-Net-Current-Asset-Value | 84.43 | |||||
Earnings Yield (Greenblatt) % | -0.5 | |||||
FCF Yield % | 3.01 | |||||
Forward Rate of Return (Yacktman) % | -2.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cofco Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 20,781.702 | ||
EPS (TTM) (Â¥) | -0.14 | ||
Beta | 1.14 | ||
3-Year Sharpe Ratio | -0.78 | ||
3-Year Sortino Ratio | -1.01 | ||
Volatility % | 33.21 | ||
14-Day RSI | 52.72 | ||
14-Day ATR (Â¥) | 0.159248 | ||
20-Day SMA (Â¥) | 5.9445 | ||
12-1 Month Momentum % | -11.63 | ||
52-Week Range (Â¥) | 4.42 - 6.82 | ||
Shares Outstanding (Mil) | 1,859.72 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cofco Biotechnology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cofco Biotechnology Co Ltd Stock Events
Event | Date | Price (Â¥) | ||
---|---|---|---|---|
No Event Data |
Cofco Biotechnology Co Ltd Frequently Asked Questions
What is Cofco Biotechnology Co Ltd(SZSE:000930)'s stock price today?
When is next earnings date of Cofco Biotechnology Co Ltd(SZSE:000930)?
Does Cofco Biotechnology Co Ltd(SZSE:000930) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |